Skip to main content
Log in

Adalimumab

Eosinophilic oesophagitis: 2 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Faust B, et al. Development of eosinophilic esophagitis following adalimumab treatment in two adolescents with crohn's disease. American Journal of Gastroenterology 116 (Suppl.): S1503 abstr. S3679, Oct 2021. Available from: URL: http://doi.org/10.14309/01.ajg.0000788248.60599.01 [abstract]

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Adalimumab. Reactions Weekly 1885, 19 (2021). https://doi.org/10.1007/s40278-021-06778-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-06778-9

Navigation